The solutions offered by the company will help meet basic, applied, and clinical research demands, providing unique in vitro assays.
The company also supports research and development of novel biopharmaceutical and vaccine products operating through its GLP compliant laboratory facilities.
VaxyGen Assay Services CEO David Dodd said VaxyGen Assay Services would ensure that their clients can depend on them to deliver quality client service and scientific service in support of their biological assay service needs.